Stock short-sellers gain from claims of shady dealings by China Medical
This article was originally published in Clinica
Executive Summary
China Medical Technologies' share price has plummeted to an all-time low after a short seller accused the company of defrauding investors. The Beijing-based, Nasdaq-listed medtech firm has denied the allegations, saying the claims concern matters previously disclosed in its annual reports and that the facts had been misrepresented.